Header image

Pfizer Breakfast Symposium: VYNDAMAX and ATTR-CM: What Cardiologists Need to Know

Tracks
Arrhythmia / EP
Mechanisms and Preclinical Discovery
Clinical / Surgical
Heart Failure
Imaging
Multidisciplinary
Paediatrics / Adult Congenital
Other
EHJ / HLC
ANZET
Friday, August 2, 2024
7:15 AM - 8:15 AM
Riverview Room 5

Details

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed, life-threatening condition that can often be overlooked as a cause of heart failure. Early diagnosis and treatment are critical for improving outcomes in patients.1 VYNDAMAX® is the first and only approved treatment for ATTR-CM, and it is now PBS reimbursed.2-4 Join our expert panel to hear about the prevalence of ATTR-CM in Australia, the key signs and symptoms to be aware of in suspecting Cardiac Amyloidosis and best practice recommendations in using non-invasive tests to ensure an accurate diagnosis and optimal outcomes for your patients. References: 1. Witteles RM et al. JACC Heart Fail 2019;7:709–16. 2. VYNDAMAX Product Information. 3. Pharmaceutical Benefits Scheme (www.pbs.gov.au). 4. Therapeutic Goods Administration - https://www.tga.gov.au/search?keywords=ATTR-CM&submit=Search.


Speaker

Agenda Item Image
Dr Jay Baumwol
Cardiologist
Fiona Stanley Hospital

VYNDAMAX and ATTR-CM: What Cardiologists Need to Know.

7:15 AM - 8:15 AM

Biography

Dr Jay Baumwol is an expert in the management of heart failure. His areas of interests include cardiomyopathy, advanced heart failure, cardiac transplantation, mechanical circulatory support, cardiac amyloidosis, and echocardiography. Jay graduated medicine with honours from the University of Western Australia. He undertook his general physician and cardiology training at St Vincent’s Hospital Sydney where he also completed a Fellowship in Echocardiography, and further trained in advanced heart failure & cardiac transplantation. He then completed a Clinical Fellowship in Advanced Heart Failure & Cardiac Transplantation at Toronto General Hospital, Canada, and also undertook further echocardiography training at Mount Sinai Hospital and Toronto General Hospital, Canada. Dr Baumwol is a Consultant Cardiologist at Fiona Stanley Hospital and St John of God Murdoch. He is a member of the West Australian Advanced Heart Failure and Cardiac Transplant Service at Fiona Stanley Hospital. He has presented at international conferences and is an active participant in clinical research.
loading